Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medicine for consumers. Illustration: Mallory Brangan
Don’t miss a WSJ video, subscribe here:
More from the Wall Street Journal: Visit WSJ.com: Visit the WSJ Video Center:
On Facebook: On Twitter: On Snapchat:
kenneth frazier,donald trump,WHOLESALER,PHARMACY,INSURANCE COMPANY,DRUGS,MEDICINE,PHARMACY BENEFIT MANAGER,PBM,MIDDLE MEN,PHARMA,DRUG PRICING,HEALTH CARE,REBATE,FORMULARY,LIST PRICE,COPAY,PHARMACEUTICAL COMPANIES,HUMALOG,U.S. DRUG PRICES,U.S. HEALTH COSTS,DEDUCTIBLE,WSJ EXPLAINER,INSURANCE PREMIUMS,CEO COUNCIL LONDON 2019,Merck,Prescription Drugs,Pharmacy Benefit Management,Pharmaceuticals Wholesale,Pharmaceuticals,Pharmacies,Drug Stores,Generic,Political,
0 Comments